Open Access
Intra-arterial chemotherapy as second-line treatment for advanced retinoblastoma
Journal Of Cancer Research And TherapeuticsPeer ReviewedHua Jiang +32018Journals
To evaluate the effectiveness and complications of intra-arterial chemotherapy (IAC) for treating advanced refractory retinoblastoma (RB) in a large single-center cohort.

The content you want is available to Zendy users.

Already have an account? Sign in
Having issues? Contact support